Jin Cao
CIK: 0002128770
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
2 Form 3 filings on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 2 Form 3 filings on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Cao Jin
Cao Jin (SEC CIK 0002128770) files insider reports with the SEC as Chief Accounting Officer of ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG).
Signal8 holds 2 ownership filings by Cao Jin, all Form 3s, filed between Apr 10, 2026 and Apr 20, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Cao Jin's filings is in ROCKVILLE, MD.
Other insiders filing for ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
- Miyara Faical, Chief Business Officer
- Zhai Yifan, Chief Medical Officer
- Yang Dajun, Chairman and CEO
- Misra Veet, Chief Financial Officer
- Wei Ren, Director
- Ye Changqing, Director